Design Decisions: Cottage industry pioneer
Profile: Boldly improving quality
Day in the Life: Dancing with a star
By Shelly Mesure
by Eleanor Feldman Barbera, Ph.D.
By Gary Tetz
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.